Blood cancers, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at a drug called 90Y ibritumomab tiuxetan (Zevalin) as a first treatment for follicular lymphoma.
Recruitment start: 30 June 2007
Recruitment end: 8 April 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Illidge
Bayer-Schering Pharma
Experimental Cancer Medicine Centre (ECMC)
The Christie NHS Foundation Trust
Last reviewed: 7 November 2012
CRUK internal database number: 1088
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
